ChiralMEM - A novel concept for high density magnetic memory technology

ChiralMEM - 高密度磁存储技术的新颖概念

基本信息

  • 批准号:
    EP/G005591/1
  • 负责人:
  • 金额:
    $ 14.22万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2009
  • 资助国家:
    英国
  • 起止时间:
    2009 至 无数据
  • 项目状态:
    已结题

项目摘要

Modern information and communication technology from personal computers to mobile phones contains electronic memory technology. Magnetic Random Access Memory (MRAM) is a new non-volatile computer memory that is widely regarded as having the potential to become the gold standard for memory. It is based on new physics called spintronics (that involves the interaction of electric current with magnetism) and stores the digital 1s and 0s of electronics as one of two directions of the magnetization of nanomagnets that form the memory in MRAM. The benefits of MRAM compared to other types of memory called SRAM, DRAM and Flash come from the speed of writing and reading data and the fact that the memory is saved even when there is no power (non-volatile). These fundamental benefits have promoted wide investment and development in MRAM and the first product was launched in July 2006. However, MRAM is in stiff competition with other technologies in a multi-billion dollar electronic memory market and must continuously improve the amount of data that can be stored in a given space - called memory density. This memory density challenge along with lower power requirements are critical issues that must be addressed for the future of MRAM.The ChiralMEM concept is a new approach to higher density MRAM for information and communication technology. The concept is based upon creating memory cells capable of storing multiple bits of information per cell in contrast to the conventional single bit (1or 0) per cell of existing technologies. Importantly, ChiralMEM is compatible with existing magnetic memory technology. These improvements combine to reduce costs and power consumption of traditional MRAM and may go on to allow use in applications such as;+ mobile hand held an consumer electronics,+ substitutes for battery plus SRAM+ Instant On computers and memory recovery from power loss+ displacement of SRAM, DRAM and Flash solutionsThe capacity of ChiralMEM to store multiple data bits in a single cell is achieved by controlling the formation of multiple magnetic states in a ferromagnetic nanowire. This control depends upon the chirality or 'type' of domain wall boundary that is formed during the data 'write' process. In technological application the memory state will be 'readout' as an electrical resistance that can have multiple values depending on the magnetic state of the memory cell. The physical processes central to this memory concept involve controlling the magnetization behaviour by selection of the domain wall chirality and were elucidated in Durham through a combination of experimental work and computational simulations. The first results were published very recently in the journal Applied Physics Letters.To understand the potential of ChiralMEM it is proposed that new technical research is undertaken to develop a series of concept demonstrators exploring technologically critical issues including maximum bit-densities and operating margins to excite the interest of commercial companies. This new knowledge will feed directly into the parallel business development work involving market research to understand wider market issues and define a meaningful technology route map for potential partners, and importantly, business development will actively promote ChiralMEM through direct interaction with potential commercial partners.At the end of the twelve month funding period the best possible result will be working demonstration structures together with a detailed commercial knowledge and an agreement with a commercial partner to take ChiralMEM to the next stage towards product development.
从个人计算机到移动的电话的现代信息和通信技术包含电子存储器技术。磁性随机存取存储器(MRAM)是一种新的非易失性计算机存储器,被广泛认为有可能成为存储器的黄金标准。它基于称为自旋电子学的新物理学(涉及电流与磁性的相互作用),并将电子的数字1和0存储为形成MRAM存储器的纳米磁体的两个磁化方向之一。MRAM与其他类型的存储器(SRAM、DRAM和闪存)相比,其优势在于写入和阅读数据的速度,以及即使在没有电源(非易失性)的情况下也能节省内存。这些基本优势促进了MRAM的广泛投资和开发,第一款产品于2006年7月推出。然而,MRAM在数十亿美元的电子存储器市场中与其他技术竞争激烈,必须不断提高可以存储在给定空间中的数据量-称为存储器密度。这种存储器密度的挑战沿着较低的功率要求是MRAM的未来必须解决的关键问题。ChiralMEM概念是用于信息和通信技术的更高密度MRAM的新方法。该概念是基于创建能够在每个单元中存储多位信息的存储器单元,而不是现有技术的每个单元中的常规单位(1或0)。重要的是,ChiralMEM与现有的磁存储器技术兼容。这些改进联合收割机降低了传统MRAM的成本和功耗,并且可以继续允许在以下应用中使用:+移动的手持消费电子产品,+电池的替代品加上SRAM+即时启动计算机和从断电中恢复存储器+SRAM的位移,DRAM和闪存解决方案ChiralMEM在单个单元中存储多个数据位的能力是通过控制多个铁磁纳米线中的磁性状态。这种控制取决于在数据“写入”过程中形成的畴壁边界的手性或“类型”。在技术应用中,存储器状态将被“读出”为电阻,该电阻可以具有取决于存储器单元的磁状态的多个值。这个存储器概念的核心物理过程涉及通过选择畴壁手性来控制磁化行为,并且在达勒姆通过实验工作和计算模拟的组合来阐明。第一批结果发表在最近的《应用物理快报》上。为了了解ChiralMEM的潜力,建议进行新的技术研究,以开发一系列概念演示器,探索技术关键问题,包括最大比特密度和运营利润,以激发商业公司的兴趣。这些新知识将直接用于并行的业务开发工作,包括市场研究,以了解更广泛的市场问题,并为潜在合作伙伴确定有意义的技术路线图,重要的是,业务发展将通过与潜在商业合作伙伴的直接互动积极促进ChiralMEM。在12个月的资助期结束时,最好的结果将是工作示范结构,以及详细的商业知识和与商业合作伙伴的协议,将ChiralMEM带到产品开发的下一个阶段。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Scaling Behaviour of Chirality Dependent Domain Wall Pinning in Planar Nanowires
平面纳米线中手性相关畴壁钉扎的缩放行为
  • DOI:
    10.12693/aphyspola.118.719
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0.7
  • 作者:
    Eastwood D
  • 通讯作者:
    Eastwood D
ChirlaMEM: A Novel Concpet for High Density Magnetic Memory Technology
ChirlaMEM:高密度磁存储技术的新颖概念
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J King
  • 通讯作者:
    J King
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Derek Atkinson其他文献

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
  • DOI:
    10.1186/1742-4690-8-s2-p76
  • 发表时间:
    2011-10-03
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Ellen Van Gulck;Viggo F Van Tendeloo;Erika Vlieghe;Marc Vekemans;Ann Van de Velde;Evelien Smits;Sébastien Anguilie;Nathalie Cools;Barbara Stein;Griet Nijs;Herman Goossens;Liesbet Mertens;Winni De Haes;Céline Merlin;Derek Atkinson;Johnsson Wong;Eric Florence;Guido Vanham;Zwi N Berneman
  • 通讯作者:
    Zwi N Berneman

Derek Atkinson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Derek Atkinson', 18)}}的其他基金

Current-driven Domain Wall Motion in Artificial Magnetic Domain Structures
人工磁畴结构中电流驱动的畴壁运动
  • 批准号:
    EP/G010897/1
  • 财政年份:
    2009
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Research Grant

相似国自然基金

Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
  • 批准号:
    82070530
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
  • 批准号:
    32002421
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
  • 批准号:
    31902347
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Positive STEM Experiences for Underrepresented and Rural 6-12th Graders: A Novel Approach to Pre-Collegiate Neuroscience using a Train-the-Trainer Model, Summer Immersion, and Sustained Mentorship
为代表性不足和农村 6-12 年级学生提供积极的 STEM 体验:利用培训师培训模型、暑期沉浸式学习和持续指导的大学预科神经科学新方法
  • 批准号:
    10665443
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Identifying adolescent social media response in real-time: Risk and protective factors for Asian American mental health
实时识别青少年社交媒体反应:亚裔美国人心理健康的风险和保护因素
  • 批准号:
    10814674
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Demonstrating miniaturized production of a KOR PET tracer as a proof-of-concept for low-cost distribution of nascent PET neurotracers
展示 KOR PET 示踪剂的小型化生产,作为新兴 PET 神经示踪剂低成本分销的概念验证
  • 批准号:
    10822523
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Incorporating Youth Voices in Community-Based Intervention Development to Improve Diet Quality and Physical Activity
将青年的声音纳入社区干预措施的制定中,以改善饮食质量和身体活动
  • 批准号:
    10677062
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
CBL0137 联合 Ipilimumab 和 Nivolumab 治疗局部晚期或转移性黑色素瘤的 I 期概念验证研究
  • 批准号:
    10722873
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Development and Piloting of a Stigma Assessment Tool for Global Pediatric Cancer
全球儿童癌症耻辱评估工具的开发和试点
  • 批准号:
    10844719
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
SMART POR: Supporting and Mentoring Across Respiratory Topics in Patient Oriented Research
SMART POR:支持和指导以患者为导向的研究中的呼吸主题
  • 批准号:
    10591121
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Ketamine to reduce postpartum depression and pain after cesarean delivery
氯胺酮可减轻产后抑郁和剖腹产后的疼痛
  • 批准号:
    10752797
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Decoding mental concept identities using electrocorticography
使用皮层电图解码心理概念身份
  • 批准号:
    10652023
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Metformin as a novel, mechanistic treatment of fibromyalgia; a proof of concept RCT
二甲双胍作为纤维肌痛的新型机械治疗方法;
  • 批准号:
    10655834
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了